S. Flynn

Identification of small molecule inhibitors of proline-rich tyrosine kinase 2 (Pyk2) with osteogenic activity in osteoblast cells.

W. Richards, Matthew R. Lee, D. Bauer, 2009, Bioorganic & medicinal chemistry letters.

Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis.

M. Morrison, A. Coxon, D. Whittington, 2008, Journal of medicinal chemistry.

Discovery of aryl aminoquinazoline pyridones as potent, selective, and orally efficacious inhibitors of receptor tyrosine kinase c-Kit.

E. Hu, R. Kunz, N. Chen, 2008, Journal of medicinal chemistry.

Novel 2-aminopyrimidine carbamates as potent and orally active inhibitors of Lck: synthesis, SAR, and in vivo antiinflammatory activity.

P. Gallant, M. Morrison, D. Elbaum, 2006, Journal of medicinal chemistry.